Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07311733Not ApplicableNot Yet Recruiting

Milky Way Sensor: Device Validation for Infiltrated Tissues

Role: lead

NCT07228416Not ApplicableNot Yet Recruiting

Milky Way Sensor Motion Validation

Role: lead

NCT04064229Not ApplicableCompleted

ivWatch Sensor: Device Validation for Infiltrated Tissues

Role: lead

NCT04065373Not ApplicableCompleted

ivWatch SmartTouch Sensor: Device Validation for Non-Infiltrated Tissues

Role: lead

NCT02553421Not ApplicableCompleted

Optical Detection of Intravenous Infiltration:A Pilot Study

Role: lead

NCT02120443Not ApplicableCompleted

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

Role: lead

NCT02123745Not ApplicableCompleted

ivWatch Model 400: Device Validation for Infiltrated Tissues

Role: lead

NCT01800552Completed

Ultrasound Detection of Peripheral IV Infiltration

Role: lead

NCT01476293Completed

Monitoring the Peripheral Intravenous Infusion Site for Infiltration and Extravasation

Role: lead

All 9 trials loaded